Abstract
The heat shock (HS) response is crucial for cell survival in harmful environments. Nuclear lamin A/C, encoded by the LMNA gene, contributes towards altered gene expression during HS, but the underlying mechanisms are poorly understood. Here, we show that upon HS, lamin A/C was reversibly phosphorylated at serine 22 in concert with HSF1 activation in human cells, mouse cells and Drosophila melanogaster in vivo. Consequently, the phosphorylation facilitated nucleoplasmic localization of lamin A/C and nuclear sphericity in response to HS. Interestingly, lamin A/C knock-out cells showed deformed nuclei after HS and were rescued by ectopic expression of wild-type lamin A, but not by a phosphomimetic (S22D) lamin A mutant. Furthermore, HS triggered concurrent downregulation of lamina-associated protein 2α (Lap2α, encoded by TMPO) in wild-type lamin A/C-expressing cells, but a similar response was perturbed in lamin A/C knock-out cells and in LMNA mutant patient fibroblasts, which showed impaired cell cycle arrest under HS and compromised survival at recovery. Taken together, our results suggest that the altered phosphorylation stoichiometry of lamin A/C provides an evolutionarily conserved mechanism to regulate lamina structure and serve nuclear adaptation and cell survival during HS.
| Original language | English |
|---|---|
| Journal | Journal of Cell Science |
| Volume | 136 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - 15 Feb 2023 |
| MoE publication type | A1 Journal article-refereed |
Funding
This project was supported by grants received from the Academy of Finland (338678 to P.T.), the Sigrid Jusélius Foundation (Sigrid Juséliuksen Säätiö) (to P.T.) and the Finnish Foundation for Cardiovascular Research (Sydäntutkimussäätiö) (to P.T. and L.V.). L.V. was supported by the Turku Doctoral Programme of Molecular Medicine and grants from the Finnish Cultural Foundation (Suomen Kulttuurirahasto), the University of Turku (Turun Yliopisto) and the Otto A. Malm foundation (Otto A. Malm Lahjoitusrahasto). Open access funding provided by the University of Turku. Deposited in PMC for immediate release. This project was supported by grants received from the Academy of Finland (338678 to P.T.), the Sigrid Jusélius Foundation (Sigrid Juséliuksen Säätiö) (to P.T.) and the Finnish Foundation for Cardiovascular Research (Sydäntutkimussäätiö) (to P.T. and L.V.). L.V. was supported by the Turku Doctoral Programme of Molecular Medicine and grants from the Finnish Cultural Foundation (Suomen Kulttuurirahasto), the University of Turku (Turun Yliopisto) and the Otto A. Malm foundation (Otto A. Malm Lahjoitusrahasto). Open access funding provided by the University of Turku. Deposited in PMC for immediate release.